SAITTA, Carlo
 Distribuzione geografica
Continente #
EU - Europa 4.318
NA - Nord America 4.233
AS - Asia 2.221
SA - Sud America 779
AF - Africa 90
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.653
Nazione #
US - Stati Uniti d'America 4.154
RU - Federazione Russa 1.483
SG - Singapore 961
BR - Brasile 700
IE - Irlanda 694
CN - Cina 620
SE - Svezia 560
IT - Italia 499
HK - Hong Kong 270
DE - Germania 257
PL - Polonia 234
FI - Finlandia 148
VN - Vietnam 125
GB - Regno Unito 110
UA - Ucraina 99
IN - India 74
FR - Francia 67
BE - Belgio 37
MX - Messico 34
CA - Canada 32
AR - Argentina 31
NL - Olanda 28
ZA - Sudafrica 28
AT - Austria 27
BD - Bangladesh 27
CI - Costa d'Avorio 22
ID - Indonesia 19
CZ - Repubblica Ceca 18
TR - Turchia 18
JP - Giappone 16
PK - Pakistan 14
ES - Italia 13
IQ - Iraq 13
EC - Ecuador 12
MA - Marocco 12
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 9
EE - Estonia 8
EG - Egitto 8
PY - Paraguay 8
VE - Venezuela 8
JO - Giordania 7
NZ - Nuova Zelanda 7
CH - Svizzera 6
KE - Kenya 6
AL - Albania 5
CO - Colombia 5
IL - Israele 5
KG - Kirghizistan 5
LV - Lettonia 5
UY - Uruguay 5
GH - Ghana 4
NP - Nepal 4
OM - Oman 4
AU - Australia 3
BO - Bolivia 3
CL - Cile 3
JM - Giamaica 3
PE - Perù 3
PS - Palestinian Territory 3
TN - Tunisia 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
DZ - Algeria 2
GD - Grenada 2
GE - Georgia 2
IR - Iran 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GL - Groenlandia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 11.650
Città #
Moscow 780
Dallas 717
Dublin 694
Ashburn 612
Singapore 529
Chandler 513
Nyköping 333
Hong Kong 270
Messina 249
Beijing 240
Jacksonville 227
Warsaw 226
The Dalles 121
Ann Arbor 120
Los Angeles 120
Dearborn 107
Munich 89
Princeton 84
Medford 79
São Paulo 68
New York 67
Cambridge 62
Des Moines 60
Boardman 56
Houston 51
Helsinki 44
Turku 42
Buffalo 41
Bremen 39
Brussels 37
Ho Chi Minh City 37
Jinan 34
Tianjin 32
Redondo Beach 31
Shenyang 26
Brasília 25
Hyderabad 25
Pune 25
Brooklyn 23
Abidjan 22
Nuremberg 22
Wilmington 22
Belo Horizonte 21
Frankfurt am Main 21
Hanoi 21
Rio de Janeiro 21
Catania 20
Nanjing 20
San Mateo 19
Boston 18
Dong Ket 18
Woodbridge 18
Lancaster 17
Orem 17
Rome 17
Santa Clara 17
Tokyo 16
Guangzhou 15
Haikou 15
Jakarta 15
Chennai 14
Denver 14
Johannesburg 14
London 14
Vienna 14
Amsterdam 13
Avola 13
Montreal 13
Zhengzhou 13
Atlanta 12
Düsseldorf 12
Hebei 12
Seattle 12
Haiphong 11
Hangzhou 11
Phoenix 11
Porto Alegre 11
Stockholm 11
Curitiba 10
Mexico City 10
Ningbo 10
Poplar 10
Taizhou 10
Brno 9
Campinas 9
Chicago 9
Falls Church 9
Lahore 9
Lappeenranta 9
Palermo 9
Ankara 8
Fuzhou 8
Rosolini 8
Cairo 7
Council Bluffs 7
Manchester 7
Olomouc 7
Sorocaba 7
Tashkent 7
Amman 6
Totale 7.737
Nome #
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 216
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 210
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 204
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 202
Atrial fibrillation in patients with cirrhosis 191
Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. 190
Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients 183
A 1-year study on hydroxy-methylglutaryl coenzymea reductase gene expression and polymorphisms in hypercholesterolemic treated with statins. 172
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 171
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 169
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 168
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 167
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 165
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 164
Ateromasia carotidea e livelli lipidici in soggetti affetti da DM2: risultati di una analisi retrospettiva 157
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 157
Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians 154
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 154
ANTIOXIDANT CAPACITY OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS (EPCS) AND CIGARETTE SMOKING 153
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 153
C-Reactive Protein (CRP) plasma levels, monocyte MCP-1 (Monocyte Chemoattractant Protein-1) and TF (Tissue Factor) mRNA in patients with primary arterial hypertension 151
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 148
Pulse wave velocity and augmentation index, but notintima-media thickness, are early indicators ofvascular damage in hypercholesterolemic children 146
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 145
Biglycan expression is increased in hypertensive subjects with normal or increased carotid intima-media wall thickness 143
Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number 143
Erectile dysfunction in compensated liver cirrhosis 141
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 138
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness 136
Anatomic variations: a rare variant of formation of the portal vein 133
Circulating progenitor cells and the elderly: a seven-year observational study. 132
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 131
Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. 130
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 129
Mitochondrial DNA is a target of HBV integration 128
Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population 127
Capacità antiossidante delle cellule progenitrici endoteliali ed abitudine al fumo di sigaretta 126
Potenziali indicatori di longevità in una popolazione di anziani siciliani 123
Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment 122
Obesity and liver cancer 122
879 CHOLANGIOPATHY AND HCC IN MDR3 DEFICIENCY 120
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 120
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 120
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness. 119
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 119
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 118
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 116
Circulating progenitor cells and high density lipoprotein levels in elderly 116
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 114
Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness 114
Olmesartan and atorvastatin are effective in improving circulating progenitor cells profile in hypertensive subjects 113
The changing scenario of hepatocellular carcinoma in Italy: an update 113
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 112
CIRCULATING PROGENITOR CELLS AND HIGH DENSITY LIPOPROTEIN LEVELS IN ELDERLY 109
XXI National Congress of the Italian Society for the Study of Arteriosclerosis (SISA) 21–24 November, Perugia, Italy 109
Pattern of macrovascular invasion in hepatocellular carcinoma 108
Fever and rhomboid target lesion in decompensated cirrhosis 106
Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians. 105
Identification of extracellular superoxide dismutase, EC-SOD, mutations in a Sicilian population 103
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 103
Tissue factor expression and activity are not increased in peripheral monocytes isolated from uncomplicated hypertensive patients 102
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 100
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 96
Smoke exposure and circulating progenitor cells: Evidence for modulation of antioxidant enzymes and cell count 96
Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy 94
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 1 93
Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina 89
Oxidative stress and flogosis: The role of endothelial progenitor cells in rheumathoid arthtritis 89
Monofocal hepatocellular carcinoma: How much does size matter? 86
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 86
Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individuals 85
PAF-AH gene polymorphisms and carotid atherosclerosis in sicilian hypercholesterolemic subjects 83
Arterial hypertension as a comorbidity of cirrhosis 81
Left Ventricular Function in Hypertension: New Insight by Speckle Tracking Echocardiography. 81
ACUTE KIDNEY INJURY IN CIRRHOTIC PATIENTS UNDERGOING CONTRAST-ENHANCED COMPUTED TOMOGRAPHY 77
The paraoxonase promoter polymorphism (-107)T > C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients 77
Virological profiles in hepatitis B virus / hepatitis C virus co-infected patients under interferon plus ribavirin therapy. 75
Occult hepatitis B virus and hepatocellular carcinoma. 75
Treatment of the Hepatitis B Virus and Hepatitis C Virus Combined Infection: Still a Challenge for the Hepatologist. 74
Hepatocellular carcinoma: the point of view of the hepatitis B virus. 74
Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness. 74
Vit d deficiency, depletion of circulating endothelial progenitor cells and impaired arterial stiffness in patients with ra 74
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 73
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 2 73
Tissue Factor and Monocyte Chemoattractant Protein-1 expression in hypertensive subjects with normal or increased carotid intima-media thickness 72
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 72
OCCULT HBV IS HIGHLY PREVALENT IN PATIENTS WITH INTRAHEPATIC CHOLANGIOCARCINOMA AND IT IS DETECTED AS BOTH FREE EPISOMAL AND INTEGRATED DNA 71
Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. 70
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus hepatitis C virus-coinfected patients 69
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 67
Toll-like receptor 3 and interleukine 1b expression in circulating progenitor cells isolated from patients with rheumatoid arthritis 67
Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness. 66
null 66
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 63
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 61
Atezolizumab plus Bevacizumab after first-line multikinase inhibitors for advanced hepatocellular carcinoma: The concept of “drug class change” 60
Occult hepatitis B virus infection: an update 54
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 53
Absence of Viral Replication Is Associated With Improved Outcome in Anti‐HCV‐Positive Patients With Hepatocellular Carcinoma 51
null 50
Totale 11.470
Categoria #
all - tutte 40.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.475


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021333 0 0 0 0 0 49 46 50 26 96 30 36
2021/2022622 11 55 21 25 27 15 37 23 9 128 88 183
2022/20231.950 143 209 78 157 163 179 25 128 808 10 37 13
2023/2024495 37 81 27 40 33 111 3 27 2 49 22 63
2024/20252.544 30 71 76 155 162 130 95 455 591 161 248 370
2025/20264.443 426 628 624 499 652 1.614 0 0 0 0 0 0
Totale 11.912